- Record: found
- Abstract: not found
- Article: not found
LBA55 Primary analysis of a phase II single-arm trial of trastuzumab deruxtecan (T-DXd) in western patients (Pts) with HER2-positive (HER2+) unresectable or metastatic gastric or gastroesophageal junction (GEJ) cancer who progressed on or after a trastuzumab-containing regimen
E. van Cutsem ,
M. Di Bartolomeo ,
E. Smyth ,
I. Chau ,
H. Park ,
S. Siena ,
S. Lonardi ,
Z.A. Wainberg ,
J.A. Ajani ,
J. Chao ,
J. Seraj ,
Y. Kawaguchi ,
A. Qin ,
J. Singh ,
G. Meinhardt ,
G. Ku
September 2021
September 2021
Read this article at
There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.